Controversies in Allergy: Aspirin Desensitization or Biologics for Aspirin-Exacerbated Respiratory Disease—How to Choose is a research paper published in The Journal of Allergy and Clinical Immunology In Practice (2022). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institute of Allergy and Infectious Diseases
Grant: K23AI141694
American Academy of Allergy, Asthma and Immunology Foundation
Grant: U19 AI095219
GlaxoSmithKline
National Institutes of Health
Bristol-Myers Squibb
Genentech
AstraZeneca
FWCI
3.59
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords